MURLENTAMAB
UNII ZN0DUZ3M4L

Substance Identification & Data

This profile provides standardized clinical and technical data for Murlentamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZN0DUZ3M4L.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2058047-65-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

ZN0DUZ3M4L

CAS Registry Number

2058047-65-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

MURLENTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C136985

National Cancer Institute reference terminology for clinical and research data.

INN ID

10858

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Murlentamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

MURLENTAMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTI-MUELLERIAN HORMONE RECEPTOR TYPE II) (HUMANIZED MONOCLONAL GM102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL GM102 .KAPPA.-CHAIN, DIMER

MURLENTAMAB [INN]

MURLENTAMAB [WHO-DD]